- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Initial remifentanil effect-site concentration
Total 1532 results
-
University of Illinois at ChicagoUCB PharmaCompletedRheumatoid ArthritisUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)Completed
-
Children's Oncology GroupNational Cancer Institute (NCI)Completed
-
M.D. Anderson Cancer CenterNational Institute of Nursing Research (NINR)Active, not recruitingAdvanced Malignant Solid Neoplasm | Hematopoietic and Lymphoid System Neoplasm | Locally Advanced Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Metastatic Malignant Solid NeoplasmUnited States
-
Organon and CoCompleted
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)TerminatedMetastatic Prostate Carcinoma | Prostate Adenocarcinoma | Stage IV Prostate Cancer | Hormone-Resistant Prostate CancerUnited States
-
University of MiamiWithdrawn
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingDyspnea | Malignant NeoplasmUnited States
-
St. Jude Children's Research HospitalCompleted
-
National Cancer Institute (NCI)RecruitingNodular Lymphocyte Predominant B-Cell Lymphoma | Recurrent Nodular Lymphocyte Predominant B-Cell Lymphoma | Refractory Nodular Lymphocyte Predominant B-Cell LymphomaUnited States
-
National Cancer Institute (NCI)RecruitingMetastatic Alveolar Soft Part Sarcoma | Unresectable Alveolar Soft Part Sarcoma | Advanced Soft Tissue Sarcoma | Advanced Alveolar Soft Part SarcomaUnited States
-
M.D. Anderson Cancer CenterTakeda; Janssen PharmaceuticalsActive, not recruitingRecurrent Primary Amyloidosis | Refractory Primary Amyloidosis | Newly Diagnosed Primary AmyloidosisUnited States
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)CompletedPain | Dysphagia | Stage I Oropharyngeal Squamous Cell Carcinoma | Stage II Oropharyngeal Squamous Cell Carcinoma | Stage III Oropharyngeal Squamous Cell CarcinomaUnited States
-
University of WashingtonNational Cancer Institute (NCI); SecuraBioTerminatedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRecurrent Adult Diffuse Large Cell Lymphoma | Intraocular Lymphoma | Central Nervous System Lymphoma | B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma | Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System and other conditionsUnited States
-
University Hospital Schleswig-HolsteinCompletedLeukemiaSwitzerland, Germany, Austria
-
Emory UniversityBristol-Myers Squibb; National Cancer Institute (NCI)RecruitingSmoldering Plasma Cell MyelomaUnited States
-
Washington University School of MedicineNational Cancer Institute (NCI); National Institutes of Health (NIH); Atrium...CompletedVentral Hernia | AdhesionsUnited States
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingRefractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingRefractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
National Cancer Institute (NCI)CompletedAnemia | Refractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedPlasma Cell Myeloma | Smoldering Plasma Cell Myeloma | Indolent Plasma Cell MyelomaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Completed
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedLeukemia | Thrombocytopenia | NeutropeniaUnited States
-
Emory UniversityNational Cancer Institute (NCI)RecruitingMetastatic Malignant Solid Neoplasm | Metastatic Malignant Neoplasm in the BrainUnited States
-
University of California, San FranciscoJanssen Pharmaceuticals; Multiple Myeloma Research FoundationTerminatedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingRefractory Plasma Cell MyelomaUnited States
-
Mayo ClinicMultiple Myeloma Research FoundationCompletedRecurrent Plasma Cell Myeloma | t(11;14)United States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingIdasanutlin, Ixazomib Citrate, and Dexamethasone in Treating Patients With Relapsed Multiple MyelomaRecurrent Plasma Cell Myeloma | Loss of Chromosome 17pUnited States
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI); Janssen Scientific Affairs, LLCWithdrawnRecurrent Plasma Cell MyelomaUnited States
-
Ohio State University Comprehensive Cancer CenterCelgeneCompletedRecurrent Plasma Cell MyelomaUnited States
-
Gruppo Italiano Malattie EMatologiche dell'AdultoCompleted
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Plasma Cell MyelomaUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedNausea and Vomiting | Malignant Digestive System NeoplasmUnited States
-
Emory UniversityNational Cancer Institute (NCI); GlaxoSmithKlineRecruitingPlasma Cell MyelomaUnited States
-
National Cancer Institute (NCI)RecruitingLung Non-Small Cell Carcinoma | Stage II Lung Cancer AJCC v8 | Stage I Lung Cancer AJCC v8United States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingSmoldering Plasma Cell MyelomaUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI); Oncolytics BiotechCompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | Multiple Myeloma-Light Chain OnlyUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedRecurrent Ovarian Carcinoma | Ovarian Neoplasm | Ovarian Clear Cell Tumor | Adnexal Mass | Ovarian Endometrioid Tumor | Ovarian Serous Tumor | Borderline Ovarian Epithelial TumorUnited States
-
National Cancer Institute (NCI)WithdrawnRefractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | t(11;14) Negative
-
Mayo ClinicNational Cancer Institute (NCI)WithdrawnAmyloidosis | Immunoglobulin Light Chain Deposition
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | LeukemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8 | Metastatic Kidney Medullary Carcinoma | SMARCB1 NegativeUnited States
-
New York Medical CollegeRecruitingHodgkin Lymphoma | Non-hodgkin LymphomaUnited States
-
University of OxfordBill and Melinda Gates Foundation; Department for International Development... and other collaboratorsRecruitingSevere Acute Respiratory SyndromeGhana, Indonesia, Nepal, South Africa, United Kingdom, Vietnam, India